Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Jesusa Entlicher"'
Autor:
Bernd Jilma, Martin Aigner, Jesusa Entlicher, Christa Drucker, Hans-Georg Eichler, Nicole Hergovich
Publikováno v:
Clinical Pharmacology & Therapeutics. 68:435-442
Background Serotonin is a platelet agonist and potent vasoconstrictor that has recently received attention concerning its potential role in acute coronary artery thrombosis. Selective serotonin-reuptake inhibitors, such as paroxetine, are widely used
Autor:
Leopold Schmetterer, Bettina Matulla, Michael Wolzt, Jeanette Koller-Strametz, Markus Müller, Hans-Georg Eichler, Jesusa Entlicher
Publikováno v:
Life Sciences. 62:1035-1042
Nitric oxide (NO) is a potent endothelium-derived vasodilator, which is known to play an important role in the regulation of resting vascular tone in animals and humans. However, the degree to which NO is involved in exercise-induced vasodilation in
Autor:
Oliver Findl, Stefan Pieh, Michael Wolzt, Leopold Schmetterer, Jesusa Entlicher, Hans-Georg Eichler, Bettina Matulla, Gabriele Streit, Ursula Graselli
Publikováno v:
British Journal of Clinical Pharmacology. 44:369-375
Aims The introduction of specific inhibitors of AT1 receptors, such as losartan, has enabled the investigation of the renin-angiotensin-system (RAS) in humans in vivo. We studied the role of the RAS in the cerebral and ocular circulation in healthy s
Autor:
Hans-Georg Eichler, Georg Zelger, Jesusa Entlicher, Michael Wolzt, Guido T. Dorner, Stylianos Kapiotis, Leopold Schmetterer
Publikováno v:
The Journal of Clinical Endocrinology & Metabolism. 82:2548-2551
It has been suggested that PTH-related peptide-(1–34) (PTHrP) is a regulator or modulator of regional or systemic cardiovascular function with varying vasodilating actions in different species. We have studied the cardiovascular pharmacodynamic pro
Autor:
Michaela Eder, Ansgar Weltermann, Paul A. Kyrle, Michael Wolzt, Hans-Georg Eichler, Jesusa Entlicher
Publikováno v:
Thrombosis and haemostasis. 78(2)
SummaryIn a double-blind, randomized, cross-over study the effects of single subcutaneous doses of 120 anti-Xa units/kg body wt. of three different low molecular weight heparin (LMWH) preparations were investigated in 15 healthy subjects by determina